SCHEMBL5823012

SCHEMBL5823012

Nc1ccccc1[C@H]1CCN(c2nc(-c3cccc(F)c3F)c3ccc(F)cc3n2)C1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.36
PRKCB P05771 1/20 0.36
PRKCA P17252 1/20 0.36
PRKCH P24723 1/20 0.36
PRKCE Q02156 1/20 0.36
PRKCQ Q04759 1/20 0.36
PRKCD Q05655 1/20 0.36
SCN9A Q15858 2/20 0.34
SLC6A9 P48067 1/20 0.33
MAPK14 Q16539 2/20 0.32
MAPK13 O15264 1/20 0.32
MAPK12 P53778 1/20 0.32
KCNH2 Q12809 1/20 0.32
MAPK11 Q15759 1/20 0.32
PTPN11 Q06124 1/20 0.32
ADORA2A P29274 2/20 0.32
PIK3CA P42336 2/20 0.32
PDE10A Q9Y233 1/20 0.32
HTR1A P08908 1/20 0.32
DRD2 P14416 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6327624 0.83 PIM1 (0.41) PRKCBPRKCAPRKCHPRKCEPRKCQ
SCHEMBL5802080 0.83 PIM1 (0.41) PRKCBPRKCAPRKCHPRKCEPRKCQ
SCHEMBL5787181 0.76 ALDH1A1 (0.48) PRKCBPRKCAPRKCHPRKCEPRKCQ
SCHEMBL6335744 0.74 ADORA2A (0.43) SCN9AADORA2APIM1
SCHEMBL6330871 0.74 ADORA2A (0.43) SCN9AADORA2APIM1
SCHEMBL6329198 0.73 NTRK1 (0.43) PRKCBPRKCAPRKCHPRKCEPRKCQ
SCHEMBL6337012 0.73 NTRK1 (0.43) PRKCBPRKCAPRKCHPRKCEPRKCQ
SCHEMBL6334984 0.73 NTRK1 (0.43) PRKCBPRKCAPRKCHPRKCEPRKCQ
SCHEMBL5785657 0.72 L3MBTL1 (0.42) SCN9AADORA2AHTR2A
SCHEMBL5789600 0.71 BPTF (0.43) SCN9APTPN11ADORA2AHTR6PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1685115-A1 NOVEL NOREPINEPHRINE REUPTAKE INHIBITORS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS Warner-Lambert Company LLC (US) 2006-08-02 EP disclosed
WO-2005042501-A1 NOVEL NOREPINEPHRINE REUPTAKE INHIBITORS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS WARNER-LAMBERT COMPANY LLC (US) 2005-05-12 WO disclosed